Immune Cell-Mediated Retinoblastoma Development: Genetic and Molecular Mechanisms

Area of Science:

• Genetics
• Immunology
• Pediatric Oncology

Background:

• Retinoblastoma (RB) is the most common pediatric eye malignancy, arising from mutations in the RB1 tumor suppressor gene.
• The precise mechanisms by which immune cells influence RB development and RB1 gene expression remain largely unknown.
• RB is inherited in an autosomal recessive manner, requiring biallelic inactivation of the RB1 gene.

Purpose of the Study:

• To investigate the potential relationship between immune cell profiles and the RB1 gene.
• To explore the role of immune cells in the etiology of retinoblastoma.
• To identify molecular mechanisms underlying immune cell involvement in RB pathogenesis.

Main Methods:

• Two-sample Mendelian randomization (MR) analysis utilizing genome-wide association study (GWAS) summary statistics.
• Single-cell RNA sequencing (scRNA-seq) for analyzing alterations in RB tissue cells.
• Identification of instrumental variables (IVs) representing immune cell traits associated with RB1.

Main Results:

• Identified 28 immune cell types significantly associated with the RB1 gene.
• Found differential gene expression within RB tumor tissues.
• Overlapping genes (EZH2, UBLCP1, HKDC1) were identified between immune cell IVs and RB tissue expression.

Conclusions:

• Immune cell variations may influence retinoblastoma risk by altering parental RB1 gene expression.
• Specific immune cells and molecular pathways (e.g., involving EZH2, UBLCP1, HKDC1) are implicated in RB development.
• Further research is warranted to elucidate the functional role of these immune cells in retinoblastoma pathogenesis.